{"id":"W1963879883","doi":"10.1111/j.1365-2141.2008.07353.x","title":"Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Rituximab; Lymphoma; Medicine; Cancer research; Oligonucleotide; Hodgkin lymphoma; Monoclonal; Internal medicine; Oncology; Monoclonal antibody; Immunology; Chemistry; Antibody; Biochemistry; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000171224,0.0002011181,0.001079967,0.0004448048,0.00006881155,0.00001041216,0.00009666599,0.00007895569,0.00001785216],"category_scores_gemma":[0.00004228843,0.0001706666,0.00007484711,0.0003127015,0.0001286536,0.0001747191,0.00004136237,0.0001579795,0.000003161928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002073098,"about_ca_system_score_gemma":0.0002302114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005813617,"about_ca_topic_score_gemma":0.0007825842,"domain_scores_codex":[0.9979574,0.0001661415,0.0008984605,0.0002471267,0.0004334158,0.0002974503],"domain_scores_gemma":[0.998635,0.0000705742,0.0006212143,0.0001657282,0.0003766801,0.0001307893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004694717,0.1617922,0.7516353,0.00007854052,0.0001712939,0.06530356,0.001937494,0.000005167148,0.00001779174,0.000002354558,0.0001892856,0.01417229],"study_design_scores_gemma":[0.2458579,0.01983917,0.7164579,0.0009800914,0.0001737532,0.01546775,0.0005540117,0.00005271799,0.000455055,0.000002710947,0.00002755808,0.0001313609],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982052,0.0005554779,0.000005149708,0.0001014089,0.0001003712,0.0009362015,0.00001003763,0.000005821339,0.00008028178],"genre_scores_gemma":[0.999033,0.000295965,0.0005333322,0.00005759015,0.00001160012,0.00001897747,0.00001460771,0.00002483341,0.0000100316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2411632,"threshold_uncertainty_score":0.6959581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01035893087214734,"score_gpt":0.2494229310716023,"score_spread":0.2390640001994549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}